We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Losartan Potassium

News List

Teva Pharmaceuticals issues voluntary nationwide recall of Losartan Potassium biospectrumasia
April 29, 2019
Teva promptly notified Golden State Medical Supply of the presence of the impurity in Hetero’s API and Teva will recall thirty-five (35) lots of bulk Losartan Potassium tablets sold to that company.
Sandoz Issues Recall of Losartan Potassium, Hydrochlorothiazide americanpharmaceuticalreview
November 10, 2018
Sandoz is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level. This product is being recalled due to the trace amount of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Losar